How Pharma Can Fix Its Reputation and Its Business at the Same Time
Harvard Business Review
FEBRUARY 3, 2017
The estimated return on these (fewer) products has itself declined substantially since 2010, from 10.1% Ethical conduct is particularly important in emerging markets where companies rely heavily on governments’ goodwill for market access and health care investments. Enhance corporate reputations.
Let's personalize your content